ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 135 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,580,000 | +63.4% | 1,081,912 | +58.8% | 0.04% | +11.8% |
| Q4 2016 | $967,000 | +242.9% | 681,091 | +322.0% | 0.03% | +277.8% |
| Q3 2016 | $282,000 | -44.2% | 161,401 | -38.9% | 0.01% | -43.8% |
| Q3 2015 | $505,000 | -88.8% | 264,177 | -72.7% | 0.02% | -86.9% |
| Q2 2015 | $4,494,000 | +37.8% | 968,446 | +3.3% | 0.12% | +69.4% |
| Q4 2014 | $3,262,000 | +2018.2% | 937,241 | +4586.2% | 0.07% | +1700.0% |
| Q2 2013 | $154,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |